GKOS
GLAUKOS Corp
NYSE · Healthcare · Medical - Devices · US
$251.84
+8.07%Forward multiples
Based on analyst estimates
- P/E forward
- 175.09x
- P/E 2026E
- 413.88x
- P/E 2027E
- 179.43x
- P/E 2028E
- 101.80x
- P/S forward
- 15.72x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 20.78x
- Price / sales
- 21.60x
- Price / cash flow
- 312.47x
Enterprise value
- Enterprise value
- $14.7B
- EV / sales
- 21.26x
- EV / EBITDA
- -118.34x
- EV / EBIT
- -231.82x
- Market cap
- $14.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026